ABVC Biopharma Inc ABVC
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2004-11-09 |
| Shares Out. | 26,000,000 |
| Website | abvcpharma.com/ ↗ |
| Phone | 15106680881 |
| Employees | 19 |
| Net Income | -$1.7M |
| Free Cash Flow | -$3.3M |
| Total Assets | $19.7M |
| Total Liabilities | $6.9M |
| Equity | $12.8M |
About ABVC Biopharma Inc
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.
ABVC Biopharma Inc is a publicly traded company under the ticker symbol ABVC on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
6 analysts (2023-10-01)